Subcutaneous bortezomib for treatment of TEMPI syndrome.
Journal: Clinical Lymphoma, Myeloma & Leukemia
Published:
Authors
Relevant Conditions
Similar Publications
We couldn’t find any related articles. Please check for more on the main search page.